Literature DB >> 8559373

Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: report of two cases and review of the literature.

N B Fountain1, D A Eberhard.   

Abstract

Early diagnosis is essential for the effective management of primary angiitis of the CNS (PACNS), but the presence of cerebrovascular amyloid angiopathy (CAA) may complicate the pathologic diagnosis since nonvasculitic inflammatory reactions can accompany CAA. We report two patients with PACNS associated with CAA in whom the progression of symptoms ceased during combined corticosteroid/cyclophosphamide therapy. One patient had prominent eosinophilic vasculitis and eosinophilic CSF pleocytosis. Based on review of reported cases, features supporting the diagnosis of symptomatic vasculitis in these patients include subacute progression of mental status changes and multifocal deficits, elevated ESR and CSF protein, and multifocal nonhemorrhagic lesions on imaging studies. We conclude that combined disease (PACNS/CAA) is similar to PACNS and probably occurs more frequently than expected by coincidence. The presence of CAA should not alter the treatment strategy in patients presenting with symptoms and laboratory studies consistent with PACNS.

Entities:  

Mesh:

Year:  1996        PMID: 8559373     DOI: 10.1212/wnl.46.1.190

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  MR spectroscopy in the diagnosis of cerebral amyloid angiopathy presenting as a brain tumor.

Authors:  Yair Safriel; Gordon Sze; Kaye Westmark; Joachim Baehring
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

2.  Advances in our Understanding of the Pathophysiology, Detection and Management of Cerebral Amyloid Angiopathy.

Authors:  Octavio M Pontes-Neto; Eitan Auriel; Steven M Greenberg
Journal:  Eur Neurol Rev       Date:  2012

3.  Eosinophilic vasculitis in an isolated central nervous system distribution.

Authors:  R Brian Sommerville; James M Noble; Jean Paul Vonsattel; Robert Delapaz; Clinton B Wright
Journal:  BMJ Case Rep       Date:  2009-02-02

4.  Aβ-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis.

Authors:  Carlo Salvarani; Gene G Hunder; Jonathan M Morris; Robert D Brown; Teresa Christianson; Caterina Giannini
Journal:  Neurology       Date:  2013-09-27       Impact factor: 9.910

5.  Pseudotumoral presentation of cerebral amyloid angiopathy-related inflammation.

Authors:  Solène Ronsin; Gianluca Deiana; Ana Filipa Geraldo; Françoise Durand-Dubief; Laure Thomas-Maisonneuve; Maïté Formaglio; Virginie Desestret; David Meyronet; Norbert Nighoghossian; Yves Berthezène; Jérôme Honnorat; François Ducray
Journal:  Neurology       Date:  2016-02-05       Impact factor: 9.910

6.  Eosinophilic vasculitis in an isolated central nervous system distribution.

Authors:  R B Sommerville; J M Noble; J P Vonsattel; R Delapaz; C B Wright
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-08-22       Impact factor: 10.154

Review 7.  Vasculitis of the central nervous system.

Authors:  P M Moore
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.592

Review 8.  Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment.

Authors:  Raoul P Kloppenborg; Edo Richard; Marieke E S Sprengers; Dirk Troost; Piet Eikelenboom; Paul J Nederkoorn
Journal:  J Neuroinflammation       Date:  2010-03-09       Impact factor: 8.322

Review 9.  Primary central nervous system vasculitis mimicking brain tumour: case report and literature review.

Authors:  Song-Bin Qu; Sofia Khan; Hua Liu
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

Review 10.  The pathophysiology and clinical presentation of cerebral amyloid angiopathy.

Authors:  Eitan Auriel; Steven Mark Greenberg
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.